✦ LIBER ✦

E-47. Combined modality therapy in older patients with stage III NSCLC and limited SCLC

✍ Scribed by Langer, Corey J.

Book ID: 118571323
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 481 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)90454-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The value of combined-modality therapy i

The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer

✍ Steven E. Schild; Sumithra J. Mandrekar; Aminah Jatoi; William L. McGinnis; Phil 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

## Abstract ## BACKGROUND. The objective of this study was to assess the value of combined‐modality therapy in elderly patients by comparing the differences in outcome between patients who received radiotherapy (RT) alone and patients who received RT plus chemotherapy for stage III nonsmall cell l

Post-chemotherapy gross tumor volume is

Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy

✍ Stinchcombe, Thomas E.; Morris, David E.; Moore, Dominic T.; Bechtel, John H.; H 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 164 KB